检索结果 - Kirkpatrick, Lynn
- Showing 1 - 6 results of 6
-
1
-
2
The PPARγ agonist pioglitazone prevents the hyperglycemia caused by phosphoinositide-3-kinase pathway inhibition by PX-866 without affecting antitumor activity 由 Ihle, Nathan T., Lemos, Robert, Schwartz, David, Oh, Junghwan, Halter, Robert J., Wipf, Peter, Kirkpatrick, Lynn, Powis, Garth
出版 2009Text -
3
Dynamic Contrast-Enhanced and Diffusion MRI Show Rapid and Dramatic Changes in Tumor Microenvironment in Response to Inhibition of HIF-1α Using PX-478 由 Jordan, Bénédicte F, Runquist, Matthew, Raghunand, Natarajan, Baker, Amanda, Williams, Ryan, Kirkpatrick, Lynn, Powis, Garth, Gillies, Robert J
出版 2005Text -
4
Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice 由 Jacoby, Jörg J., Erez, Baruch, Korshunova, Maria V., Williams, Ryan R., Furutani, Kazuhisa, Takahashi, Osamu, Kirkpatrick, Lynn, Lippman, Scott M., Powis, Garth, O’Reilly, Michael S., Herbst, Roy S.
出版 2010Text -
5
An inhibitor of the pleckstrin homology domain of CNK1 selectively blocks the growth of mutant KRAS cells and tumors 由 Indarte, Martin, Puentes, Roisin, Maruggi, Marco, Ihle, Nathan T., Grandjean, Geoffrey, Scott, Michael, Ahmed, Zamal, Meuillet, Emmanuelle J., Zang, Shuxing, Lemos, Robert, Du-Cuny, Lei, Layng, Fabiana I. A. L., Correa, Ricardo G., Bankston, Laurie A., Liddington, Robert C., Kirkpatrick, Lynn, Powis, Garth
出版 2019Text -
6
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer 由 Jeung, Hei-Cheul, Puentes, Roisin, Aleshin, Alexander, Indarte, Martin, Correa, Ricardo G., Bankston, Laurie A., Layng, Fabiana I.A.L., Ahmed, Zamal, Wistuba, Ignacio, Yao, Yong, Duenas, Daniela G., Zhang, Shuxing, Meuillet, Emmanuelle J., Marassi, Francesca, Liddington, Robert C., Kirkpatrick, Lynn, Powis, Garth
出版 2021Text